0DHC Stock Overview Operates as a medical technology company in Germany, rest of Europe, North America, and Asia. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Carl Zeiss Meditec AG Competitors Price History & Performance
Summary of share price highs, lows and changes for Carl Zeiss Meditec Historical stock prices Current Share Price €47.91 52 Week High €123.30 52 Week Low €44.28 Beta 1.06 1 Month Change 4.37% 3 Month Change -25.57% 1 Year Change -52.20% 3 Year Change -66.39% 5 Year Change -60.24% Change since IPO 380.18%
Recent News & Updates
ZEISS Medical Technology Receives U.S. FDA Approval; Completes Corneal Refractive Workflow Jan 13
Investor sentiment deteriorates as stock falls 22% Dec 17
Carl Zeiss Meditec AG to Report Q1, 2025 Results on Feb 12, 2025 Dec 12
Full year 2024 earnings released: EPS: €2.01 (vs €3.25 in FY 2023) Dec 12
New minor risk - Share price stability Dec 11
Carl Zeiss Meditec AG to Report Fiscal Year 2024 Results on Dec 11, 2024 Dec 04 See more updates
ZEISS Medical Technology Receives U.S. FDA Approval; Completes Corneal Refractive Workflow Jan 13
Investor sentiment deteriorates as stock falls 22% Dec 17
Carl Zeiss Meditec AG to Report Q1, 2025 Results on Feb 12, 2025 Dec 12
Full year 2024 earnings released: EPS: €2.01 (vs €3.25 in FY 2023) Dec 12
New minor risk - Share price stability Dec 11
Carl Zeiss Meditec AG to Report Fiscal Year 2024 Results on Dec 11, 2024 Dec 04
Investor sentiment improves as stock rises 16% Sep 27
Now 21% overvalued Sep 27
Now 21% undervalued after recent price drop Sep 02
New minor risk - Share price stability Aug 15
New minor risk - Profit margin trend Aug 08
Now 21% undervalued after recent price drop Aug 03
Investor sentiment deteriorates as stock falls 22% Jun 19
Carl Zeiss Meditec AG to Report Nine Months, 2024 Results on Aug 06, 2024 Jun 18
Now 27% undervalued after recent price drop Jun 18
ZEISS Announces OCT Technology Enhancements to Better Support Growing Era of Data-Driven Patient Care May 31
Second quarter 2024 earnings released: EPS: €0.52 (vs €0.69 in 2Q 2023) May 11
Carl Zeiss Meditec AG (XTRA:AFX) completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF). Apr 05 Carl Zeiss Meditec AG (XTRA:AFX) completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF). Apr 04
Upcoming dividend of €1.10 per share Mar 15
First quarter 2024 earnings released: EPS: €0.42 (vs €0.57 in 1Q 2023) Feb 15
Carl Zeiss Meditec AG to Report First Half, 2024 Results on May 08, 2024 Feb 10
Carl Zeiss Meditec AG, Annual General Meeting, Mar 21, 2024 Jan 18
Carl Zeiss Meditec AG Announces U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS Jan 12
Full year 2023 earnings released: EPS: €3.25 (vs €3.29 in FY 2022) Dec 14
Investor sentiment improves as stock rises 18% Dec 12
Now 21% undervalued after recent price drop Nov 13
Now 21% undervalued after recent price drop Oct 02
ZEISS Reimagined the Iconic Pentero Platform for Digital Age Sep 13
Third quarter 2023 earnings released: EPS: €1.03 (vs €0.70 in 3Q 2022) Aug 08
Upcoming dividend of €1.10 per share at 0.8% yield Mar 16
First quarter 2023 earnings released: EPS: €0.57 (vs €0.42 in 1Q 2022) Feb 19
Full year 2022 earnings released: EPS: €3.29 (vs €2.64 in FY 2021) Dec 10 Carl Zeiss Meditec AG to Report Q1, 2023 Results on Feb 10, 2023
Carl Zeiss Meditec AG Reaffirms Earning Guidance for 2022 May 14
Carl Zeiss Meditec AG (XTRA:AFX) acquired Kogent Surgical, LLC and Katalyst Surgical, LLC. Apr 20
Upcoming dividend of €0.90 per share Mar 24
First quarter 2022 earnings: Revenues and EPS in line with analyst expectations Feb 16
Carl Zeiss Meditec AG Reaffirms Earnings Guidance for the Year 2021/22 Feb 12
Investor sentiment deteriorated over the past week Jan 13
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Dec 11
Investor sentiment deteriorated over the past week Sep 30
Upcoming dividend of €0.50 per share May 21
Second quarter 2021 earnings released: EPS €0.61 (vs €0.28 in 2Q 2020) May 12
Carl Zeiss Meditec AG Provides Earnings Guidance for the Year 2021 May 11
Carl Zeiss Meditec AG Provides Earnings Guidance for the Year 2021 Apr 20
First quarter 2021 earnings released: EPS €0.52 (vs €0.43 in 1Q 2020) Feb 10
Revenue beats expectations Feb 10
New 90-day high: €132 Feb 02
Carl Zeiss Meditec AG, Annual General Meeting, May 27, 2021 Dec 17 Carl Zeiss Meditec AG to Report Nine Months, 2021 Results on Aug 06, 2021
New 90-day high: €122 Oct 14
ZEISS Presents its New Solution Enhancements to Help Doctors Maximize Clinical Efficiency and Improve Patient Care - from Assessment, Diagnosis, to Treatment Oct 04
New 90-day high: €101 Sep 18
New 90-day high - €95.45 Aug 27
New 90-day high - €94.65 Aug 10 Shareholder Returns 0DHC GB Medical Equipment GB Market 7D 5.8% 5.4% 3.2% 1Y -52.2% -6.0% 10.9%
See full shareholder returns
Return vs Market: 0DHC underperformed the UK Market which returned 10.9% over the past year.
Price Volatility Is 0DHC's price volatile compared to industry and market? 0DHC volatility 0DHC Average Weekly Movement 6.3% Medical Equipment Industry Average Movement 6.3% Market Average Movement 4.8% 10% most volatile stocks in GB Market 10.7% 10% least volatile stocks in GB Market 2.6%
Stable Share Price: 0DHC has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0DHC's weekly volatility (6%) has been stable over the past year.
About the Company Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Show more Carl Zeiss Meditec AG Fundamentals Summary How do Carl Zeiss Meditec's earnings and revenue compare to its market cap? 0DHC fundamental statistics Market cap €4.22b Earnings (TTM ) €178.73m Revenue (TTM ) €2.07b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 0DHC income statement (TTM ) Revenue €2.07b Cost of Revenue €977.50m Gross Profit €1.09b Other Expenses €909.90m Earnings €178.73m
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 12, 2025
Earnings per share (EPS) 2.04 Gross Margin 52.69% Net Profit Margin 8.65% Debt/Equity Ratio 19.6%
How did 0DHC perform over the long term?
See historical performance and comparison Dividends
1.2% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/18 15:39 End of Day Share Price 2025/01/17 00:00 Earnings 2024/09/30 Annual Earnings 2024/09/30
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Carl Zeiss Meditec AG is covered by 31 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Samuel England Berenberg Scott Bardo Berenberg Julien Ouaddour BofA Global Research
Show 28 more analysts 
